LeMaitre Vascular, Inc. (LMAT) Social Stream
Lemaitre Vascular Inc (LMAT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Lemaitre Vascular Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 5 | $70 | $58 | $62.5 | $47.59 | 31.33% |
| 2022-01-06 | 5 | $70.001 | $58 | $62.5 | $47.59 | 31.33% |
| 2022-01-21 | 5 | $70.001 | $48 | $59.5 | $47.59 | 25.03% |
| 2022-02-24 | 5 | $65 | $48 | $58.25 | $47.59 | 22.4% |
| 2022-02-25 | 5 | $65 | $48 | $56.25 | $47.59 | 18.2% |
| 2022-03-29 | 5 | $65 | $48 | $53.75 | $47.59 | 12.94% |
The Trend in the Analyst Price Target
LMAT's average price target has moved down $6.05 over the prior 46 weeks.
LMAT reports an average of 15.28% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-03 | 5 | 76 | 55 | 62.00 | 59.74 | 3.78% |
| 2021-08-01 | 5 | 76 | 55 | 64.00 | 54.46 | 17.52% |
| 2021-09-20 | 6 | 76 | 58 | 66.14 | 55.16 | 19.91% |
| 2022-02-25 | 5 | 65 | 48 | 56.25 | 46.48 | 21.02% |
| 2022-03-29 | 5 | 65 | 48 | 53.75 | 46.29 | 16.12% |
LMAT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.2 | 2 | 0 | 3 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
LMAT's average broker recommendation rating improved by 0 over the prior 28 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Lemaitre Vascular Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 186.96% of that group.
- LMAT has a greater average analyst price target than 645% of stocks in the small market cap category.
- Lemaitre Vascular Inc's upside potential (average analyst target price relative to current price) is greater than 147.1% of Healthcare stocks.
- In the context of Healthcare stocks, Lemaitre Vascular Inc's variance in analysts' estimates is lower than -94.22% of them.
Stocks similar to Lemaitre Vascular Inc in the Medical Equipment industry regarding analyst recommendations and price targets are LGV, KRMD, and KIDS.
What is the outlook for LMAT? Use POWR Ratings for clearer insight into price direction.